Printer Friendly

NCINVEST 2004 Presenter Profiles.

Business Editors

NCINVEST 2004

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Feb. 25, 2004

NCINVEST 2004 takes place on February 26, 2004 at The Friday Center in Chapel Hill, North Carolina. For in-depth information about the event visit http://www.ncinvest.org/about.html.

Below are profiles from NCINVEST 2004 presenters; breaking news releases are available at http://www.tradeshownews.com, Business Wire's trade show and conference news resource.

Company: Charles & Colvard Ltd.
Ticker Symbol: CTHR
Investor Relations Contact: Jim Braun
Phone: 919 468 0399
E-mail: jbraun@moissanite.com
Company URL: moissanite.com

Moissanite is near colorless jewel, that has more fire, brilliance and
luster than a fine diamond, but retails for only a fraction of the
cost. Moissanite jewels are produced from silicon carbide (SiC)
crystals. Moissanite jewelry is sold in fine jewelry stores, on
domestic and international shopping networks, in catalogs and online.

Charles & Colvard Ltd. is the sole source of moissanite, a created
jewel used in fine jewelry. Charles & Colvard creates a range of sizes
and shapes of sparkling moissanite jewels, which it sells to jewelry
manufacturers and exclusive distributors in the U.S. and abroad.
Charles and Colvard has the patent for the use of silicon carbide
(SiC) as a jewel.

Company: Closure Medical Corporation
Ticker Symbol: CLSR
Media Contact: Benny Ward
Investor Relations Contact: Benny Ward
Phone: 919.876.7800
E-mail: info@closuremedical.com
Company URL: www.closuremed.com
Press Area URL:
www.closuremed.com/index.cfm/fuseaction/page/filename/newsreleases
.html

Closure's leading product, DERMABOND adhesive, is sold to healthcare
professionals and can be used instead of sutures or staples. Other
products developed by the Company include BAND-AID(R) Brand Liquid
Bandage and Orabase(R) SOOTHE-N-SEAL(R) canker sore relief. In
addition, the company has two veterinary products in its NEXABAND(R)
product line.

Closure Medical Corporation develops and manufactures innovative
biomaterial-based medical devices for wound care and wound closure for
healthcare practitioners, patients and consumers based on its
proprietary medical grade cyanoacrylate technology. The Company's
research efforts have also included the development of internal
adhesive products.

Company: Cree, Inc.
Ticker Symbol: CREE
Media Contact: Fran Barsky
Investor Relations Contact: Fran Barsky
Phone: 919-313-5397
E-mail: fran_barsky@cree.com
Company URL: www.cree.com

Cree, Inc. develops and manufactures semiconductor materials and
electronic devices made from silicon carbide (SiC) and gallium nitride
(GaN). The Company uses its proprietary technology to produce compound
semiconductors such as blue and green light emitting diodes (LEDs) for
use in automotive, mobile appliances and liquid crystal displays
(LCD); full color indoor and outdoor displays; indicator lamps, and
other lighting applications. The Company also manufacturers and sells
SiC wafers which are used for research directed toward optoelectronic,
microwave and power device applications.

Company: Embrex, Inc.
Ticker Symbol: EMBX
Media Contact: Ellen Moore
Investor Relations Contact: Ellen Moore
Phone: (919) 314-2561
E-mail: emoore@embrex.com
Company URL: www.embrex.com

Embrex products:

Inovoject(R) egg injection system vaccinates poultry while it is still
in the egg.

Egg Remover(R) identifies infertile and early dead eggs and removes
them from tray before vaccination.

Bursaplex(R) IBD vaccine is the only single-dose effective IBD vaccine
that safely protects birds in the presence of maternal antibody.

Embrex, Inc., The In Ovo Company(SM )(Nasdaq: EMBX), is an
international agricultural biotechnology company focused on developing
and commercializing patented biological, pharmaceutical and mechanical
and that improve bird health, reduce bird production costs and provide
economic benefits to the global poultry industry.

Company: EnPro Industries, Inc.
Ticker Symbol: NPO
Media Contact: Don Washington
Investor Relations Contact: Don Washington
Phone: 704 731-1527
E-mail: don.washington@enproindustries.com
Company URL: www.enproindustries.com
Press Area URL:
http://www.corporate-ir.net/ireye/ir_site.zhtml?ticker=NPO&script=400

EnPro Industries, Inc., with 2003 sales of $730 million, is a leader
in sealing products, metal polymer bearings, compressor systems,
diesel and dual-fuel engines and other engineered products for use in
critical applications by industries worldwide. The company employs
over 4,400 people and is headquartered in Charlotte, NC.

Company: Piedmont Natural Gas
Ticker Symbol: PNY
Media Contact: Steve Conner
Investor Relations Contact: Headen Thomas
Phone: 704-731-4438
E-mail: headen.thomas@piedmontng.com
Company URL: www.piedmontng.com
Press Area URL:
http://ir.thomsonfn.com/InvestorRelations/PubNews.aspx?partner=Mzg0T1R
rNU5BPT1QJFkEQUALSTO&product=MzgwU1ZJPVAkWQEQUALSTOEQUALSTO

The company distributes natural gas.

Based in Charlotte, Piedmont Natural Gas (NYSE:PNY) is an energy
services company primarily engaged in the distribution of natural gas
to 940,000 residential, commercial and industrial utility customers in
North Carolina, South Carolina and Tennessee, including 60,000
customers served by municipalities who are wholesale customers. Our
subsidiaries are invested in joint venture, energy-related businesses,
including unregulated retail natural gas marketing, interstate natural
gas storage, intrastate transportation and regulated natural gas
distribution. PNY is one of the fastest-growing natural gas
distributors in the nation. Dividends have increased every year since
1978 and the average annual compound return on PNY shares has been 16%
over the past 20 years.

Company: SpectraSite, Inc.
Ticker Symbol: SSI
Media Contact: Noreen Allen
 919-465-6678
Investor Relations Contact: Investor Relations Department
 919-466-5492
E-mail: investorrelations@spectrasite.com
Company URL: www.spectrasite.com
Press Area URL: www.spectrasite.com

SpectraSite, Inc., based in Cary, North Carolina, is one of the
largest wireless tower operators in the United States. As of December
31, 2003, SpectraSite owned or operated approximately 10,000 revenue
producing sites, including 7,577 towers and in-building sites
primarily in the top 100 markets in the United States. SpectraSite's
customers are leading wireless communications providers, including
AT&T Wireless, Cingular, Nextel, Sprint PCS, T-Mobile and Verizon
Wireless.

Company: Trimeris.com
Ticker Symbol: TRMS
Media Contact: Robin Fastenau
Investor Relations Contact: Robin Fastenau
Phone: 919.419.6050
E-mail: rfastenau@trimeris.com
Company URL: www.trimeris.com
Press Area URL: http://www.trimeris.com/news/

Product description: FUZEON(R) (enfuvirtide), approved in the U.S.,
Canada and European Union, is the first in a new class of anti-HIV
drugs called fusion inhibitors. Unlike other HIV drugs that work after
the virus has infected the human immune cell, Fuzeon works outside the
cell and blocks HIV from entering.

Company description: Trimeris, Inc. is a biopharmaceutical company
based in Durham, North Carolina. The Company's mission is to discover,
develop and commercialize novel therapeutics that meet important
medical needs, and we are currently engaged in the discovery and
development of new drugs for the treatment of viral disease.

Company: TriPath Imaging, Inc.,
Ticker Symbol: TPTH
Media Contact: Jenny Kobin
Investor Relations Contact: Jenny Kobin
Phone: 919-206-7195
E-mail: jkobin@tripathimaging.com
Company URL: www.tripathimaging.com

TriPath Imaging, Inc., headquartered in Burlington, North Carolina,
develops, manufactures, markets and sells innovative solutions to
improve the clinical management of cancer, including detection,
diagnosis, staging and treatment. TriPath Oncology, a wholly owned
subsidiary of TriPath Imaging, develops molecular diagnostic and
pharmacogenomic products and services for malignant melanoma and
cancers of the cervix, breast, ovary and prostate. For more
information on the Company, please go to www.tripathimaging.com or
call (866)TRI-PATH.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 25, 2004
Words:1164
Previous Article:Computer Resolutions Inc. to Distribute New Sun Servers.
Next Article:IVAX Enters Marketing and Distribution Agreement with Mayne Pharmaceuticals for Injectable Paclitaxel in Europe.


Related Articles
Typical school day experiences of Indian children in different contexts.
Presenters wanted for 2004 ACA National Conference.
Marine and Atmospheric Sciences. (Divisional Reports).
Sixteen local associations receive grants. (Foundation News).
Seventeen local associations receive grants.
Upcoming webcasts.
New Zealand Conference on Pay and Employment Equity for Women.
Call for presentations.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters